Acadia Pharmaceuticals
Earnings Surprise
Analysts estimated ACAD earnings of $0.14 per share this quarter (Q4). ACAD's actual earnings were $1.60 per share.
ACAD EPS surprise of 1044.49%Analysts estimated ACAD earnings of $0.15 per share this quarter (Q3). ACAD's actual earnings were $0.42 per share.
ACAD EPS surprise of 178.15%Analysts estimated ACAD earnings of $0.14 per share this quarter (Q2). ACAD's actual earnings were $0.16 per share.
ACAD EPS surprise of 14.45%Analysts estimated ACAD earnings of $0.22 per share this quarter (Q4). ACAD's actual earnings were $-0.02 per share.
ACAD EPS surprise of -1202.00%Analysts estimated ACAD earnings of $0.14 per share this quarter (Q3). ACAD's actual earnings were $0.20 per share.
ACAD EPS surprise of 41.94%Analysts estimated ACAD earnings of $0.18 per share this quarter (Q2). ACAD's actual earnings were $0.20 per share.
ACAD EPS surprise of 9.83%Analysts estimated ACAD earnings of $0.05 per share this quarter (Q1). ACAD's actual earnings were $0.10 per share.
ACAD EPS surprise of 109.64%Analysts estimated ACAD earnings of $0.31 per share this quarter (Q4). ACAD's actual earnings were $0.28 per share.
ACAD EPS surprise of -9.65%